[HTML][HTML] Host-directed therapies for bacterial and viral infections
SHE Kaufmann, A Dorhoi, RS Hotchkiss… - Nature reviews Drug …, 2018 - nature.com
Despite the recent increase in the development of antivirals and antibiotics, antimicrobial
resistance and the lack of broad-spectrum virus-targeting drugs are still important issues and …
resistance and the lack of broad-spectrum virus-targeting drugs are still important issues and …
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
Tuberculosis remains the world's leading cause of death from an infectious disease,
responsible for an estimated 1 674 000 deaths annually. WHO estimated 600 000 cases of …
responsible for an estimated 1 674 000 deaths annually. WHO estimated 600 000 cases of …
[HTML][HTML] New developments in anti-malarial target candidate and product profiles
JN Burrows, S Duparc, WE Gutteridge… - Malaria journal, 2017 - Springer
A decade of discovery and development of new anti-malarial medicines has led to a
renewed focus on malaria elimination and eradication. Changes in the way new anti …
renewed focus on malaria elimination and eradication. Changes in the way new anti …
[HTML][HTML] Neutrophil extracellular traps in pulmonary diseases: too much of a good thing?
Neutrophil extracellular traps (NETs) arise from the release of granular and nuclear contents
of neutrophils in the extracellular space in response to different classes of microorganisms …
of neutrophils in the extracellular space in response to different classes of microorganisms …
A systematic review of biomarkers to detect active tuberculosis
Millions of cases of tuberculosis (TB) go undiagnosed each year. Better diagnostic tools are
urgently needed. Biomarker-based or multiple marker biosignature-based tests, ideally …
urgently needed. Biomarker-based or multiple marker biosignature-based tests, ideally …
Tuberculosis treatment monitoring and outcome measures: new interest and new strategies
J Heyckendorf, SB Georghiou, N Frahm… - Clinical microbiology …, 2022 - Am Soc Microbiol
Despite the advent of new diagnostics, drugs and regimens, tuberculosis (TB) remains a
global public health threat. A significant challenge for TB control efforts has been the …
global public health threat. A significant challenge for TB control efforts has been the …
The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules
Oxindole derivatives are known for their great interest in the field of Medicinal Chemistry, as
they display vast biological activities. Recent efforts concerning the preparation of oxindole …
they display vast biological activities. Recent efforts concerning the preparation of oxindole …
[HTML][HTML] New drugs and perspectives for new anti-tuberculosis regimens
S Tiberi, M Muñoz-Torrico, R Duarte, M Dalcolmo… - Pulmonology, 2018 - Elsevier
Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease.
With growing drug resistance the epidemic remains and will require significant attention and …
With growing drug resistance the epidemic remains and will require significant attention and …
[HTML][HTML] Chronic physical conditions, multimorbidity and physical activity across 46 low-and middle-income countries
Background There are no nationally representative population-based studies investigating
the relationship between physical activity, chronic conditions and multimorbidity (ie, two or …
the relationship between physical activity, chronic conditions and multimorbidity (ie, two or …
[HTML][HTML] Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α
Previously, we developed a 3-dimensional cell culture model of human tuberculosis (TB)
and demonstrated its potential to interrogate the host-pathogen interaction (Tezera et al …
and demonstrated its potential to interrogate the host-pathogen interaction (Tezera et al …